scispace - formally typeset
Open AccessJournal ArticleDOI

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

Homie Razavi, +6 more
- 01 Jun 2013 - 
- Vol. 57, Iss: 6, pp 2164-2170
Reads0
Chats0
TLDR
This analysis demonstrates that US HCV prevalence is in decline due to a lower incidence of infections, however, the prevalence of advanced liver disease will continue to increase as well as the corresponding healthcare costs.
About: 
This article is published in Hepatology.The article was published on 2013-06-01 and is currently open access. It has received 448 citations till now. The article focuses on the topics: Hepatitis C & Disease burden.

read more

Citations
More filters
Journal ArticleDOI

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Theo Vos, +778 more
- 16 Sep 2017 - 
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.
Journal ArticleDOI

Global, regional, and national incidence, prevalence, andyears lived with disability for 354 diseases and injuries for195 countries and territories, 1990–2017: a systematicanalysis for the Global Burden of Disease Study 2017

Gbd Disease, +11 more
- 10 Nov 2018 - 
TL;DR: All-cause age-standardised YLD rates decreased by 3·9% from 1990 to 2017; however, the all-age YLD rate increased by 7·2% while the total sum of global YLDs increased from 562 million (421–723) to 853 million (642–1100).
Journal ArticleDOI

Global Distribution and Prevalence of Hepatitis C Virus Genotypes

Jane P. Messina, +6 more
- 01 Jan 2015 - 
TL;DR: It is calculated that HCV genotype 1 is the most prevalent worldwide, comprising 83.4 million cases (46.2% of all HCV cases), approximately one‐third of which are in East Asia.
Journal ArticleDOI

ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

Fred Poordad, +16 more
- 21 May 2014 - 
TL;DR: In this phase 3 trial of an oral, interferon-free regimen evaluated exclusively in patients with HCV genotype 1 infection and cirrhosis, multitargeted therapy with the use of three new antiviral agents and ribavirin resulted in high rates of sustained virology response.
Journal ArticleDOI

Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.

Arnolfo Petruzziello, +4 more
- 14 Sep 2016 - 
TL;DR: Although HCV genotypes 1 and 3 infections are the most prevalent globally (67.0% if considered together), other genotypes are found more commonly in lower-income countries where still account for a significant proportion of HCV cases.
References
More filters
Journal ArticleDOI

The Department of Health and Human Services.

Jeaimie Stoker
- 01 Jul 1999 - 
TL;DR: This letter is in response to your two Citizen Petitions, requesting that the Food and Drug Administration (FDA or the Agency) require a cancer warning on cosmetic talc products.
Journal ArticleDOI

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

Miriam J. Alter, +7 more
- 19 Aug 1999 - 
TL;DR: The strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior, and poverty, having had 12 or fewer years of education, and having been divorced or separated were independently associated.
Journal ArticleDOI

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Thierry Poynard, +2 more
- 22 Mar 1997 - 
TL;DR: The host factors of ageing, alcohol consumption, and male sex have a stronger association with fibrosis progression than virological factors in HCV infection.
Journal ArticleDOI

Rising incidence of hepatocellular carcinoma in the United States.

Hashem B. El-Serag, +1 more
- 11 Mar 1999 - 
TL;DR: The incidence of hepatocellular carcinoma increased significantly among younger persons (40 to 60 years old) during the period from 1991 to 1995 as compared with earlier periods, and the age-specific incidence of this cancer has progressively shifted toward younger people.
Journal ArticleDOI

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Gregory L. Armstrong, +5 more
- 16 May 2006 - 
TL;DR: To determine the characteristics of HCV-infected persons in the general United States population today and to monitor trends in prevalence, data on HCV infection from the most recent NHANES was analyzed.
Related Papers (5)

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Adriaan J. van der Meer, +14 more
- 26 Dec 2012 - 

Sofosbuvir for previously untreated chronic hepatitis C infection

Eric Lawitz, +23 more
- 15 May 2013 - 

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam H. Afdhal, +23 more
- 14 May 2014 - 

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.

Khayriyyah Mohd Hanafiah, +3 more
- 01 Apr 2013 - 

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, +23 more
- 22 Jun 2011 -